-
1
-
-
0344306684
-
Association of asymmetric dimethylarginine and endothelial dysfunction
-
DOI 10.1515/CCLM.2003.225
-
Böger RH. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 2003;41(11):1467-72. (Pubitemid 37493562)
-
(2003)
Clinical Chemistry and Laboratory Medicine
, vol.41
, Issue.11
, pp. 1467-1472
-
-
Boger, R.H.1
-
2
-
-
4744339386
-
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor
-
Böger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 2004;134:2842S-7S.
-
(2004)
J Nutr
, vol.134
-
-
Böger, R.H.1
-
3
-
-
0026548912
-
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
-
Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
-
(1992)
Lancet
, vol.339
, pp. 572-575
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
4
-
-
0035936406
-
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
-
DOI 10.1016/S0140-6736(01)07217-8
-
Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001;358:2113-7. (Pubitemid 34094901)
-
(2001)
Lancet
, vol.358
, Issue.9299
, pp. 2113-2117
-
-
Zoccali, C.1
Bode-Boger, S.M.2
Mallamaci, F.3
Benedetto, F.A.4
Tripepi, G.5
Malatino, L.S.6
Cataliotti, A.7
Bellanuova, I.8
Fermo, I.9
Frolich, J.C.10
Boger, R.H.11
-
5
-
-
54249118627
-
Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia
-
Vladimirova-Kitova L, Deneva T, Angelova E, Nikolov F, Marinov B, Mateva N. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia. Clin Physiol Funct Imaging 2008;28(6):417-25.
-
(2008)
Clin Physiol Funct Imaging
, vol.28
, Issue.6
, pp. 417-425
-
-
Vladimirova-Kitova, L.1
Deneva, T.2
Angelova, E.3
Nikolov, F.4
Marinov, B.5
Mateva, N.6
-
6
-
-
0034975920
-
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
-
DOI 10.1016/S0735-1097(01)01318-3, PII S0735109701013183
-
Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001;38:111-6. (Pubitemid 32613836)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.1
, pp. 111-116
-
-
Lundman, P.1
Eriksson, M.J.2
Stuhlinger, M.3
Cooke, J.P.4
Hamsten, A.5
Tornvall, P.6
-
7
-
-
0037010008
-
Plasma asymmetric dimethylarginine and hyperaemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia
-
Päivä H, Laakso J, Laine H, Laaksonen R, Knuuti J, Raitakari OT. Plasma asymmetric dimethylarginine and hyperaemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. J Am Coll Cardiol 2002;40:1241-7.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1241-1247
-
-
Päivä, H.1
Laakso, J.2
Laine, H.3
Laaksonen, R.4
Knuuti, J.5
Raitakari, O.T.6
-
8
-
-
61949358942
-
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension
-
Wang D, Strandgaard S, Iversen J, Wilcox CS. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 2009;296(2):R195-200.
-
(2009)
Am J Physiol Regul Integr Comp Physiol
, vol.296
, Issue.2
-
-
Wang, D.1
Strandgaard, S.2
Iversen, J.3
Wilcox, C.S.4
-
9
-
-
65249119330
-
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
-
Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009;119(12):1592-600.
-
(2009)
Circulation
, vol.119
, Issue.12
, pp. 1592-1600
-
-
Böger, R.H.1
Sullivan, L.M.2
Schwedhelm, E.3
Wang, T.J.4
Maas, R.5
Benjamin, E.J.6
-
10
-
-
66349098445
-
Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
-
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, PinskyDJ, et al. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron Artery Dis 2009;20(2):112-7.
-
(2009)
Coron Artery Dis
, vol.20
, Issue.2
, pp. 112-117
-
-
Cavusoglu, E.1
Ruwende, C.2
Chopra, V.3
Yanamadala, S.4
Eng, C.5
Pinsky, D.J.6
-
11
-
-
77950975714
-
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease
-
Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, et al. A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res 2010;106(6):1145-52.
-
(2010)
Circ Res
, vol.106
, Issue.6
, pp. 1145-1152
-
-
Ding, H.1
Wu, B.2
Wang, H.3
Lu, Z.4
Yan, J.5
Wang, X.6
-
12
-
-
35549008481
-
Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: Role in platelet hyperaggregability in hypertension
-
de Meirelles LR, Mendes-Ribeiro AC, Santoro MM, Mendes MA, da Silva MN, Mann GE, et al. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension. Clin Exp Pharmacol Physiol 2007;34(12):1267-71.
-
(2007)
Clin Exp Pharmacol Physiol
, vol.34
, Issue.12
, pp. 1267-1271
-
-
De Meirelles, L.R.1
Mendes-Ribeiro, A.C.2
Santoro, M.M.3
Mendes, M.A.4
Da Silva, M.N.5
Mann, G.E.6
-
13
-
-
67650915289
-
Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes
-
Jiang DJ, Cao Y, Xin HY, Li XH, Luo ZQ, Li YJ. Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes. Atherosclerosis 2009;205(2):554-60.
-
(2009)
Atherosclerosis
, vol.205
, Issue.2
, pp. 554-560
-
-
Jiang, D.J.1
Cao, Y.2
Xin, H.Y.3
Li, X.H.4
Luo, Z.Q.5
Li, Y.J.6
-
14
-
-
12844278573
-
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
-
DOI 10.1182/blood-2004-08-3253
-
Lisman T, de Groor PG, Meijers JCM, Rosendaal FR. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005;105(3):1102-5. (Pubitemid 40170881)
-
(2005)
Blood
, vol.105
, Issue.3
, pp. 1102-1105
-
-
Lisman, T.1
De Groot, P.G.2
Meijers, J.C.M.3
Rosendaal, F.R.4
-
15
-
-
56349109855
-
The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treatedwith streptokinase
-
Nilsson JB, Boman K, Jansson JH, Nilsson T, Näslund U. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treatedwith streptokinase. J Thromb Thrombolysis 2008;26(3):188-95.
-
(2008)
J Thromb Thrombolysis
, vol.26
, Issue.3
, pp. 188-195
-
-
Nilsson, J.B.1
Boman, K.2
Jansson, J.H.3
Nilsson, T.4
Näslund, U.5
-
16
-
-
34548478103
-
Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries
-
DOI 10.1038/sj.sc.3102018, PII 3102018
-
Aito S, Abbate R, Marcucci R, Cominelli E. Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries. Spinal Cord 2007;45(9):627-31. (Pubitemid 47373820)
-
(2007)
Spinal Cord
, vol.45
, Issue.9
, pp. 627-631
-
-
Aito, S.1
Abbate, R.2
Marcucci, R.3
Cominelli, E.4
-
17
-
-
0035936390
-
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
-
DOI 10.1016/S0140-6736(01)07184-7
-
Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, et al. Risk of acute coronary events and serumconcentration of asymmetrical dimethylarginine. Lancet 2001;358(9299):2127-8. (Pubitemid 34094905)
-
(2001)
Lancet
, vol.358
, Issue.9299
, pp. 2127-2128
-
-
Valkonen, V.-P.1
Paiva, H.2
Salonen, J.T.3
Lakka, T.A.4
Lehtimaki, T.5
Laakso, J.6
Laaksonen, R.7
-
18
-
-
36448974517
-
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
-
Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, et al. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J 2007;154(6):1059-64.
-
(2007)
Am Heart J
, vol.154
, Issue.6
, pp. 1059-1064
-
-
Itakura, H.1
Sobel, B.E.2
Boothroyd, D.3
Leung, L.L.4
Iribarren, C.5
Go, A.S.6
-
19
-
-
21344439852
-
Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction
-
DOI 10.1111/j.1365-2796.2005.01507.x
-
Lundblad D, Dinesen B, Rautio A, Røder ME, Eliasson M. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction. J Intern Med 2005;258(1):13-20. (Pubitemid 40904928)
-
(2005)
Journal of Internal Medicine
, vol.258
, Issue.1
, pp. 13-20
-
-
Lundblad, D.1
Dinesen, B.2
Rautio, A.3
Roder, M.E.4
Eliasson, M.5
-
20
-
-
0036544669
-
Bradykinin enhances in vitro procoagulant and antifibrinolytic properties of rat vascular endothelial cells
-
DOI 10.1016/S0049-3848(02)00070-1, PII S0049384802000701
-
Kimura S, Tsuji H, Nishimura H, Kato H, Ukimura N, Yano S, et al. Bradykinin enhances in vitro procoagulant and antifibrinolytic properties of rat vascular endothelial cells. Thromb Res 2002;106(1):41-50. (Pubitemid 34879964)
-
(2002)
Thrombosis Research
, vol.106
, Issue.1
, pp. 41-50
-
-
Kimura, S.1
Tsuji, H.2
Nishimura, H.3
Kato, H.4
Ukimura, N.5
Yano, S.6
Kunieda, Y.7
Kawano, H.8
Nakagawa, K.9
Nakagawa, M.10
-
21
-
-
33644988090
-
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition
-
DOI 10.1161/01.HYP.0000202478.79587.1a, PII 0000426820060300000030
-
Brown NJ, Muldowney 3rd JA, Vaughan DE. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition. Hypertension 2006;47(3):441-8. (Pubitemid 43740288)
-
(2006)
Hypertension
, vol.47
, Issue.3
, pp. 441-448
-
-
Brown, N.J.1
Muldowney III, J.A.S.2
Vaughan, D.E.3
-
22
-
-
33644980666
-
Molecular mechanisms for the release of chemokines from human leukemicmast cell line (HMC)-1 cells activated by SCF and TNF-alpha: Roles of ERK, p38 MAPK, and NF-kappaB
-
Wong CK, Tsang CM, Ip WK, Lam CW. Molecular mechanisms for the release of chemokines from human leukemicmast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB. Allergy 2006;61(3):289-97.
-
(2006)
Allergy
, vol.61
, Issue.3
, pp. 289-297
-
-
Wong, C.K.1
Tsang, C.M.2
Ip, W.K.3
Lam, C.W.4
-
23
-
-
77952562069
-
Nitric oxide stimulates interleukin-6 production in skeletal myotubes
-
Makris AC, Sotzios Y, Zhou Z, Makropoulou M, Papapetropoulos N, Zacharatos P, et al. Nitric oxide stimulates interleukin-6 production in skeletal myotubes. J Interferon Cytokine Res 2010;30(5):321-7.
-
(2010)
J Interferon Cytokine Res
, vol.30
, Issue.5
, pp. 321-327
-
-
Makris, A.C.1
Sotzios, Y.2
Zhou, Z.3
Makropoulou, M.4
Papapetropoulos, N.5
Zacharatos, P.6
-
24
-
-
77952430963
-
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
-
Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, et al. Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 2010;210(1):226-31.
-
(2010)
Atherosclerosis
, vol.210
, Issue.1
, pp. 226-231
-
-
Cavusoglu, E.1
Ruwende, C.2
Chopra, V.3
Poludasu, S.4
Yanamadala, S.5
Frishman, W.H.6
-
25
-
-
69249211311
-
Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease
-
Young JM, Terrin N, Wang X, Greene T, Beck GJ, Kusek JW, et al. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol 2009;4(6):1115-20.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, Issue.6
, pp. 1115-1120
-
-
Young, J.M.1
Terrin, N.2
Wang, X.3
Greene, T.4
Beck, G.J.5
Kusek, J.W.6
-
26
-
-
65949123566
-
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis
-
Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 2009;30(9):1142-50.
-
(2009)
Eur Heart J
, vol.30
, Issue.9
, pp. 1142-1150
-
-
Antoniades, C.1
Shirodaria, C.2
Leeson, P.3
Antonopoulos, A.4
Warrick, N.5
Van-Assche, T.6
-
27
-
-
77952067397
-
Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine
-
Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N, et al. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine. Am J Pathol 2010;176(5):2559-70.
-
(2010)
Am J Pathol
, vol.176
, Issue.5
, pp. 2559-2570
-
-
Jacobi, J.1
Maas, R.2
Cardounel, A.J.3
Arend, M.4
Pope, A.J.5
Cordasic, N.6
|